Nucleix Ltd.

Nucleix Ltd.

Nucleix Ltd.

Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic bio markers.
Founded
2008
Raised
$5.9M
Follow us
Alexa global traffic share
Latest funding
€2,500,000
Venture capital - 2018
European H2020 EIC pilot SME Instrument Programme
Team Size
10+
Employees
Location
Headquarters
€2,500,000 Venture capital
FinSMEs

Cancer Detection and Screening Startup Nucleix Receives €2.5M Funding

Health Funding
$3,000,000 Seed fund
NoCamels - Israeli Tech and Innovation News , FinSMEs

Nucleix Cancer Detection Company Raises $3M

Funding